Results 81 to 90 of about 1,612 (133)

Evaluation of Ginsenosides and Their Derivatives From <i>Panax ginseng</i> as Aromatase Inhibitors for Breast Cancer Treatment-An <i>in silico</i> study. [PDF]

Biomed Res Int
Madhan JG, Sekaran S, Akshaya RN, Venkatesan K, Kirupanandasamy K, Vijayakumar K, Jenifer N, Paul BC.   +7 more
europepmc   +1 more source

<i>Aspergillus oryzae</i> solid-state fermentation enriches protopanaxatriol-type ginsenosides in <i>Panax ginseng</i> and confers cytoprotective effects <i>in vitro</i>. [PDF]

Front Microbiol
Li X, Ding H, Wang E, Wang S, Wang H, Chen C.   +5 more
europepmc   +1 more source

Revealing the effects of <i>Aspergillus cristatus</i>, golden flower fungus, fermenting on the roots of the medicinal and edible plant <i>Panax ginseng</i>. [PDF]

Front Microbiol
Wang L, Wei Q, He C, Li X, Liu S.
europepmc   +1 more source

Emerging Breakthroughs in Nano-Ginseng Innovations and Their Therapeutic Implications in Type 2 Diabetes. [PDF]

Pharmaceuticals (Basel)
Tiwari P, Park KI, Mandal S.
europepmc   +1 more source

Gintonin as a Lysophosphatidic Acid-Enriched GPCR Ligand System: Molecular Architecture and Receptor Pharmacology in <i>Panax ginseng</i>. [PDF]

Biomolecules
Kim KH, Yoo BC.
europepmc   +1 more source

Catalytic Transformation of Ginsenoside Re over Mesoporous Silica-Supported Heteropoly Acids: Generation of Diverse Rare Ginsenosides in Aqueous Ethanol Revealed by HPLC-HRMSⁿ. [PDF]

Molecules
Wang Q, Chang Y, Li B, Zhang Z, Zhao M, Zhao H, Xiu Y.   +6 more
europepmc   +1 more source

Advances in Functional Genomics and Biotechnology for Enhancing Therapeutic Potential of Medicinal Plants. [PDF]

Int J Mol Sci
Zaman W, Park S.
europepmc   +1 more source

Hot melt extruded Kyungohkgo attenuates skeletal muscle atrophy by downregulating the FOXO3a/MuRF-1/atrogin-1 axis. [PDF]

Sci Rep
Seok YM, Jin BR, Gil TY, Ryu S, Ju CY, Jeong Y, Son J, Shim MS, Kim HJ, An HJ, Baek JS, Cha YY.   +11 more
europepmc   +1 more source

In silico identification of bilobetin and ginsenoside as dual CK2 and ULK2 inhibitors targeting triple-negative breast cancer. [PDF]

Sci Rep
Hossain MA, Tamanna IJ, Hossain MS, Parvez A, Afrin S, Sobuj DR, Islam MT, Al Noman A, Ahmed M, Sultana S, Srivastava S, Rao GSNK, Khan SR, Babu MR, Tariq M, Saiyad MT, Hamzah Z, Jain M.   +17 more
europepmc   +1 more source

Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms. [PDF]

Front Pharmacol
Jin T, Du Y, Liu C, Zhao J, Liu T.
europepmc   +1 more source